​

Pyxis Oncology Ownership | Who Owns Pyxis Oncology?

OverviewForecastRevenueFinancialsChart

Pyxis Oncology Ownership Summary

Pyxis Oncology is owned by 29.10% institutional investors, 22.13% insiders, and 48.76% retail investors. Pfizer is the largest institutional shareholder, holding 11.32% of PYXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.26% of its assets in Pyxis Oncology shares.

PYXS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPyxis Oncology29.10%22.13%48.76%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Pfizer7.03M11.32%$9.21M
Laurion capital management lp5.00M8.04%$7.30M
Blackrock2.79M5.43%$9.22M
Tang capital management2.50M4.04%$5.55M
Vanguard group2.34M3.73%$2.69M
Perceptive advisors1.18M1.90%$2.62M
Palo alto investors lp1.01M1.63%$1.48M
683 capital management896.26K1.44%$1.31M
Renaissance888.68K1.43%$1.30M
Blackrock funding, inc. /de788.84K1.27%$1.15M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ridgeback capital investments359.23K100.00%$560.40K
Pfizer7.03M3.86%$9.21M
Healthinvest partners ab197.04K0.52%$1.62M
Laurion capital management lp5.00M0.32%$7.30M
Stempoint capital lp689.54K0.31%$1.53M
Palo alto investors lp1.01M0.23%$1.48M
Tang capital management2.50M0.21%$5.55M
Diadema partners lp150.00K0.09%$333.00K
Perceptive advisors1.18M0.08%$2.62M
Decheng capital326.81K0.07%$477.14K

Top Buyers

HolderShares% AssetsChange
Blackrock2.79M0.00%2.46M
Perceptive advisors1.18M0.08%1.18M
Stempoint capital lp689.54K0.31%689.54K
Jacobs levy equity management461.00K0.00%461.00K
Driehaus capital management418.63K0.01%418.63K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---4.18M
Blue owl capital lp---1.13M
Abrdn---913.04K
Ikarian capital---613.25K
Superstring capital management lp---484.44K

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors1.18M0.08%1.18M$2.62M
Stempoint capital lp689.54K0.31%689.54K$1.53M
Driehaus capital management418.63K0.01%418.63K$929.36K
Ridgeback capital investments359.23K100.00%359.23K$560.40K
Vanguard fiduciary trust300.90K0.00%300.90K$439.31K

Sold Out

HolderChange
Northwestern mutual wealth management-12.00
Ifp advisors-17.00
West branch capital-25.00
Russell investments group-64.00
Us bancorp \de\-94.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202647-41.98%18,085,721-40.11%291.25%19-60.42%14-12.50%
Dec 31, 202542-43.24%19,885,511-25.88%311.69%26-3.70%6-79.31%
Sep 30, 202571-1.39%23,143,075-14.35%371.91%26-25.71%2926.09%
Jun 30, 202574-17.78%27,483,617-9.00%451.84%369.09%23-14.81%
Mar 31, 202591-9.90%30,255,964-4.06%491.84%35-42.62%2758.82%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.42M2.26%-
HealthInvest Sustainable Healthcare E771.99K1.23%-
abrdn Healthcare Investors626.64K1.01%-
Vanguard Institutional Extnd Mkt Idx Tr560.86K0.89%3.17K
Fidelity Small Cap Index499.46K0.81%-
iShares Russell 2000 Value ETF464.56K0.75%-
iShares Biotechnology ETF340.10K0.54%2.15K
HealthInvest S&M Cap Healthcare C336.26K0.54%-
abrdn Life Sciences Investors286.41K0.46%-
State St Russell Sm/Mid Cp® Indx NL Cl C281.69K0.45%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 21, 2025HUMPHREY RACHEL-Sell$14.36K
Apr 14, 2025HUMPHREY RACHEL-Sell$1.36K
Apr 17, 2025HUMPHREY RACHEL-Sell$194.00
Nov 26, 2024Connealy Pamela Ann CFO & COOBuy$163.46K
Nov 26, 2024Connealy Pamela Ann CFO & COOBuy$10.90K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q1--
2024 Q42-
2024 Q2--
2024 Q1--

PYXS Ownership FAQ

Who Owns Pyxis Oncology?

Pyxis Oncology shareholders are primarily institutional investors at 29.10%, followed by 22.13% insiders and 48.77% retail investors. The average institutional ownership in Pyxis Oncology's industry, Biotech Stocks , is 35.75%, which Pyxis Oncology falls below.

Who owns the most shares of Pyxis Oncology?

Pyxis Oncology’s largest shareholders are Pfizer (7.03M shares, 11.32%), Laurion capital management lp (5M shares, 8.04%), and Blackrock (2.79M shares, 5.43%). Together, they hold 24.79% of Pyxis Oncology’s total shares outstanding.

Does Blackrock own Pyxis Oncology?

Yes, BlackRock owns 5.43% of Pyxis Oncology, totaling 2.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.22M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 766.09% change.

Who is Pyxis Oncology’s biggest shareholder by percentage of total assets invested?

Ridgeback capital investments is Pyxis Oncology’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 359.23K Pyxis Oncology shares, valued at 560.4K$.

Who is the top mutual fund holder of Pyxis Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Pyxis Oncology shares, with 2.26% of its total shares outstanding invested in 1.42M Pyxis Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools